Respiratory syncytial virus vaccines
CA 2417274 A1 · Owner: Parrington, Mark · Inventors: Sales, Valerie; Luciani, Mathilde; Atkins, Judith
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An immunogenic composition which may be formulated for protection of a host against disease caused by infection by Respiratory Syncytial Virus (RSV) is provided. The immunogenic preparation comprises at least one protein of RSV or at least one immunogenic fragment of the at least one protein and is not adjuvanted. The at least one RSV protein may be the F G or M protein from a , RSV A or RSV B strain. The compositions may be stabilized for storage. Methods of immunization using the immunogenic preparations are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 31, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 31, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 31, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.